Gujarat Meditech reports 610% revenue growth in FY2016 and 7.2 pp EBITDA Margin decline from 7.2% to 0%
01-07-2016 • About Gujarat Meditech (
$GUJMEDI) • By InTwits
Gujarat Meditech reported FY2016 financial results today. Overall the company's long term financial model is characterised by the following facts: It operates with medium-size leverage: Net Debt/EBITDA is 0.7x while industry average is 0.0x.
Below you can find a comprehensive analysis of the key data driving the company's performance and the stock price.
Revenue and profitability
The company's Revenue jumped on 610%.
Financial and operational results
Gujarat Meditech ($GUJMEDI) key annual financial indicators| mln. INR | 2012 | 2013 | 2014 | 2015 | 2016 | 2016/2015 |
|---|
P&L
|
|---|
| Revenue | 2.966 | 3.174 | 1.220 | 0.690 | 4.900 | 610.1% |
| EBITDA | 0.447 | 0.023 | -0.120 | 0.050 | 0.000 | -100.0% |
| Net Income | 0.312 | -0.037 | -0.150 | 0.010 | 0.000 | -100.0% |
Balance Sheet
|
|---|
Cash flow
|
|---|
Ratios
|
|---|
| Revenue growth | -99.3% | 7.0% | -61.6% | -43.4% | 610.1% | |
| EBITDA growth | | -94.9% | -621.7% | -141.7% | -100.0% | |
|
|---|
| EBITDA Margin | 15.1% | 0.7% | -9.8% | 7.2% | 0.0% | -7.2% |
| Net Income Margin | 10.5% | -1.2% | -12.3% | 1.4% | 0.0% | -1.4% |
|
|---|
Peers in Healthcare Supplies
Below we provide Gujarat Meditech benchmarking against other companies in Healthcare Supplies industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.
Top companies by Revenue growth, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Bilcare ($BI) | - | -2.6% | -13.7% | -12.1% | -4.8% |
| |
|---|
| Median (1 company) | - | -2.6% | -13.7% | -12.1% | -4.8% |
|---|
| Gujarat Meditech ($GUJMEDI) | - | 7.0% | -61.6% | -43.4% | 610.1% |
Top companies by EBITDA margin, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Shree Pacetronix ($SHREEPAC) | - | - | - | 15.9% | - |
| Bilcare ($BI) | 15.0% | 10.9% | 13.9% | 8.2% | 10.6% |
| |
|---|
| Median (2 companies) | 15.0% | 10.9% | 13.9% | 12.1% | 10.6% |
|---|
| Gujarat Meditech ($GUJMEDI) | 15.1% | 0.7% | -9.8% | 7.2% | 0.0% |
Top companies by CAPEX/Revenue, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Bilcare ($BI) | 11.0% | 29.2% | 15.4% | 0.0% | - |
| |
|---|
| Median (1 company) | 11.0% | 29.2% | 15.4% | 0.0% | - |
|---|
Top companies by ROIC, %
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Shree Pacetronix ($SHREEPAC) | - | - | - | - | - |
| Bilcare ($BI) | 12.8% | 7.3% | 2.8% | 0.9% | - |
| |
|---|
| Median (2 companies) | 12.8% | 7.3% | 2.8% | 0.9% | - |
|---|
| Gujarat Meditech ($GUJMEDI) | - | - | - | - | - |
Top companies by Net Debt / EBITDA
| Top | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Bilcare ($BI) | 2.2x | 5.2x | 4.8x | 9.7x | 0.0x |
| Shree Pacetronix ($SHREEPAC) | 2.3x | - | - | 0.0x | - |
| |
|---|
| Median (2 companies) | 2.3x | 5.2x | 4.8x | 4.9x | 0.0x |
|---|
| Gujarat Meditech ($GUJMEDI) | 0.0x | 0.0x | - | 0.0x | - |
